Data demonstrate colon tissue PDE4/cAMP pathway modulation and sustained active metabolite exposure above IC90 across the dosing ...

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...

Inflammatory bowel disease (IBD), affecting an estimated 6–8 million people worldwide, may soon be monitored with a simple ...

IBD is an immune condition. Instead of peacefully coexisting with gut microbes, the immune system becomes overly reactive, ...

KT-579 demonstrated activity comparable or superior to approved and clinically active therapies in preclinical IBD modelsKT-579 Phase 1 healthy ...

Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular, inflammatory, and fibrotic diseases, is presenting new translational data on its oral ...

There are several evidence-based lifestyle and diet changes you can make right now to support your gut. For example, eating ...

DIMAPUR: Apollo Hospitals Guwahati in association with District Hospital Dimapur (DHD) will be organising a free health check-up camp at District Hospital, Dimapur on May 16 from 11 a.m. onwards. The ...

The combination showed efficacy exceeding that of either monotherapy ...

Palisade Bio has released further phase 1a/b analyses of its investigational PDE4 inhibitor prodrug PALI‑2108, adding new ...

Chronic immune diseases are shaped by multiple inflammatory processes happening at the same time, each in different parts of ...